Blogroll

Omeros Announces Positive Data After Completion of Dosing in Phase 1 Clinical

Omeros Announces Positive Data after Completion of Dosing in Phase 1 Clinical
Adult humans who are genetically deficient in one of the proteins that activate MASP-2 do not appear to be detrimentally affected by the deficiency. Therefore, Omeros believes that it may be possible to deliver … Omeros' five other clinical programs …
Read more on Wall Street Journal

Connecting the Dots: Mapping the Brain in a Common Form of Autism — What you see here is state of the art for brain mapping today: a three-dimensional model of the wiring of a normal human brain, known as a “connectome”, deve…


Find More How Is Addiction Genetically Linked Information…